Adnexus Therapeutics, Inc. · Waltham, MA United States
Company Description
View Adnexus Therapeutics, Inc. Locations On A US Map
This link will open in a new window
The nexus of intercellular communication is protein and Adnexus plans to capitalize on that. The company makes protein-based drugs called Adnectins, which it believes deliver disease-fighting results superior to antibodies and small molecules. The Adnectins, when combined with the company's PROfusion protein-generation system, combat cancer and musculo-skeletal, neurodegenerative, and autoimmune diseases. The company hopes to avoid patent issues for already existing drugs because Adnectins have a different composition. Adnexus is a subsidiary of Bristol-Myers Squibb . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Adnexus Therapeutics, Inc. Financials
| Company Type | Subsidiary Single Location |
| Fiscal Year-End | December |
| Employees | 30 |
Adnexus Therapeutics, Inc. Executives
11 executives listed for Adnexus Therapeutics, Inc.'s Waltham, MA location.
| Title | Name & Bio | Contact |
| President | John Edwards | Network |
| Financial Consultant and Interim Chief Financial Officer | Lorin Randall | Network |
| Chief Medical Officer | Martin Freed | Network |
Competition
Competitive Landscape for Adnexus Therapeutics, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Adnexus Therapeutics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
